• Japanese
  • Korean
  • Chinese
Cover Image

China Independent Clinical Laboratory Industry Report, 2014-2017

The independent clinical laboratory industry starts relatively late in China, featuring a limited overall size but high-speed development. In 2013 the independent clinical laboratory market size there was around RMB3.5 billion, up as much as 70% yr-on-yr, yet only accounting for 2%-3% of the total revenue of medical diagnosis.

There are about 110 independent clinical laboratories in today's China, but most of them are small sized. KingMed Diagnostics, ADICON, DIAN Diagnostics and DAAN Gene as the strong performers thereof hold a combined market share of roughly 70%.

Because of a high requirement on the samples within a shorter time limit for place, the industry has a certain service radius. Therefore, a national layout is essential to business development and customer acquisition and chain-orientation the key development mode, for enterprises. KingMed Diagnostics, ADICON, DIAN Diagnostics and DAAN Gene have by far 19, 15, 14 and 8 independent medical laboratories across the country.

KingMed Diagnostics as the largest independent clinical laboratory enterprise in China enjoys a market share of approximately 40%, receiving recognition from both College of American Pathologists (CAP) and ISO15189. In the first half of 2014 it posted revenue of RMB846 million, up 37% yr-on-yr. Equipped with detection platforms for tumor diseases, genetic diseases, blood diseases, etc., KingMed Diagnostics will give top priority to tumor, reproduction and microbiological testing in the future.

ADICON is the first independent medical laboratory in domestic trans-regional chain operation, with a market share as high as 15%-18%. In recent years, many of its subsidiaries have successively won ISO15189 and CAP certificates

As an industry leader in the business model of "service + agent", DIAN Diagnostics gets involved in independent clinical laboratory, judicial expertise, diagnostic products agency and other areas. Currently, the company boasts an 18% market share in the Chinese independent clinical laboratory industry, capable of carrying out more than 1,000 medical diagnostic services.

Moreover, related enterprises abroad have also been well aware of the growth potential in China's independent clinical laboratory industry, and set foot in the Chinese market via cooperation with local companies.

In February 2012, Quest and KingMed Diagnostics entered into a strategic alliance and established the KingMed&Quest Diagnostics Alliance Laboratory. And the Tianbo Lab jointly set up bythe South Korea-based SK Group and Xi'an Tianlong Science & Technology Co.Ltd started business in July 2014.

image1

China Independent Clinical Laboratory Industry Report, 2014-2017 highlights the followings:

  • Policy environment, international market, development status, competition pattern, etc. of China's independent clinical laboratory industry;
  • Upstream and downstream markets of China's independent clinical laboratory industry and their impacts;
  • Operation, independent clinical laboratory business, etc. of 13 relevant enterprises in China;
  • Prospect for the development of China's independent clinical laboratory industry in 2014-2017 and operation comparison between key players.

Table of Contents

1. Overview of Independent Clinical Laboratory

  • 1.1 Definition
  • 1.2 Industry Chain

2. Overview of China Independent Clinical Laboratory Industry

  • 2.1 Policy Environment
    • 2.1.1 Access Policy
    • 2.1.2 Industry Policy
  • 2.2 International Market
    • 2.2.1 Status Quo
    • 2.2.2 Benchmarking Enterprises
  • 2.3 Development Status
  • 2.4 Competition Pattern

3. Upstream and Downstream Markets of China Independent Clinical Laboratory Industry

  • 3.1 Upstream Market
    • 3.1.1 Status Quo
    • 3.1.2 Competition Pattern
  • 3.2 Downstream Market
    • 3.2.1 Independent Clinical Laboratory Market Sees Huge Capacity
    • 3.2.2 Healthcare Reform Boosts the Rapid Development of Independent Clinical Laboratory Market
    • 3.2.3 Demand Diversification Promotes the Upgrading of Independent Clinical Laboratory Industry
    • 3.2.4 Healthcare Demand Growth Propels the Independent Clinical Laboratory Forward Faster

4. Key Players

  • 4.1 KingMed Diagnostics
    • 4.1.1 Profile
    • 4.1.2 Independent Clinical Laboratory
    • 4.1.3 Operation and Development
  • 4.2 ADICON
    • 4.2.1 Profile
    • 4.2.2 Independent Clinical Laboratory
    • 4.2.3 Development
  • 4.3 DIAN Diagnostics
    • 4.3.1 Profile
    • 4.3.2 Operation
    • 4.3.3 Revenue Structure
    • 4.3.4 Gross Margin
    • 4.3.5 R&D and Investment
    • 4.3.6 Independent Clinical Laboratory
    • 4.3.7 Supply and Sales
    • 4.3.8 Forecast and Outlook
  • 4.4 DAAN Gene
    • 4.4.1 Profile
    • 4.4.2 Operation
    • 4.4.3 Revenue Structure
    • 4.4.4 Gross Margin
    • 4.4.5 R&D and Investment
    • 4.4.6 Independent Clinical Laboratory
    • 4.4.7 Supply and Sales
    • 4.4.8 Forecast and Outlook
  • 4.5 NYMPHAVN Biotechnology
    • 4.5.1 Profile
    • 4.5.2 Operation
    • 4.5.3 Revenue Structure
    • 4.5.4 Gross Margin
    • 4.5.5 R&D and Investment
    • 4.5.6 Independent Clinical Laboratory
    • 4.5.7 Forecast and Outlook
  • 4.6 SurExam
    • 4.6.1 Profile
    • 4.6.2 Operation
    • 4.6.3 Gross Margin
    • 4.6.4 Independent Clinical Laboratory
    • 4.6.5 Supply and Sales
    • 4.6.6 Forecast and Outlook
  • 4.7 Amoy Diagnostics
    • 4.7.1 Profile
    • 4.7.2 Independent Clinical Laboratory
  • 4.8 CapitalBio
    • 4.8.1 Profile
    • 4.8.2 Independent Clinical Laboratory
  • 4.9 ADINOVO
    • 4.9.1 Profile
    • 4.9.2 Independent Clinical Laboratory
  • 4.10 Kindstar Global
    • 4.10.1 Profile
    • 4.10.2 Independent Clinical Laboratory
  • 4.11 Deyi Diagnostics
    • 4.11.1 Profile
    • 4.11.2 Independent Clinical Laboratory
  • 4.12 IPE-Bio
    • 4.12.1 Profile
    • 4.12.2 Independent Clinical Laboratory

5. Forecast and Outlook

  • 5.1 Industry Development
  • 5.2 Operation Comparison between Enterprises
    • 5.2.1 Revenue
    • 5.2.2 Net Income
    • 5.2.3 Net Profit Margin
    • 5.2.4 Gross Margin
    • 5.2.5 Independent Clinical Laboratory

Selected Charts

  • Independent Clinical Laboratory Industry Chain
  • Comparison of Independent Clinical Laboratory Undertakers between China and USA
  • Policies Concerning Independent Clinical Laboratory Industry in China, 2010-2013
  • U.S. Independent Clinical Laboratory Market Share by Test Item
  • U.S. Clinical Laboratory Market Share by Demand Side
  • Revenue and Net Income of Quest, 2009-2014
  • Gross Margin of Quest, 2009-2014
  • Major M&A Events of Quest Diagnostics, 2006-2014
  • Revenue and Operating Income of LabCorp, 2010-2013
  • Revenue Breakdown of LabCorp by Business, 2010-2013
  • Major M&A Events of LabCorp, 2007-2013
  • Basic Characteristics and Market Share of Major Independent Clinical Laboratory Enterprises in China, 2014
  • Market Size of In Vitro Diagnostic Industry in China, 2009-2013
  • Market Structure of In Vitro Diagnostic Industry in China, 2013
  • Comparison of Diagnostic Instrument Varieties between Domestic and Foreign Enterprises
  • Competition Pattern of Diagnostic Reagent Industry in China
  • IVD Revenue and Market Share of Major Diagnostic Reagent Enterprises in China, 2013
  • Business Revenue and Inspection Revenue of Medical Institutions in China, 2012
  • Medical Services of Health Agencies in China, 2012-2013
  • Number of Medical Institutions in China, 2012-2013
  • Health Expenditure and % of GDP in China, 1980-2013
  • Per Capita Health Expenditure and YoY Growth in China, 2006-2013E
  • Revenue of KingMed Diagnostics, 2012-2014
  • Revenue and Net Income of DIAN Diagnostics, 2009-2014
  • Revenue Breakdown of DIAN Diagnostics by Product, 2009-2014
  • Revenue Structure of DIAN Diagnostics by Product, 2009-2014
  • Revenue Breakdown of DIAN Diagnostics by Region, 2009-2014
  • Gross Margin of DIAN Diagnostics, 2009-2014
  • R&D Costs and % of Total Revenue of DIAN Diagnostics, 2010-2014
  • DIAN Diagnostics' Revenue from Independent Clinical Laboratory and YoY Growth, 2009-2014
  • Name List and Procurement of DIAN Diagnostics' Top 5 Suppliers, H1 2014
  • Name List and Procurement of DIAN Diagnostics' Top 5 Suppliers, 2013
  • Name List and Sales of DIAN Diagnostics' Top 5 Clients, H1 2014
  • Name List and Sales of DIAN Diagnostics' Top 5 Clients, 2013
  • Revenue and Net Income of DIAN Diagnostics, 2012-2017E
  • Revenue and Net Income of DAAN Gene, 2009-2014
  • Revenue Breakdown of DAAN Gene by Business, 2009-2014
  • Revenue Structure of DAAN Gene by Business, 2009-2014
  • Revenue Breakdown of DAAN Gene by Region, 2009-2014
  • Revenue Structure of DAAN Gene by Region, 2009-2014
  • Gross Margin of DAAN Gene, 2009-2014
  • Gross Margin of DAAN Gene by Business, 2009-2014
  • R&D Costs and % of Total Revenue of DAAN Gene, 2011-2014
  • Main Assets and Business of DAAN Gene
  • Industrial Chain Layout of DAAN Gene
  • Medical Resources of Sun Yat-Sen University
  • DAAN Gene's Revenue from Independent Clinical Laboratory and YoY Growth, 2009-2014
  • Top 5 Clients of DAAN Gene, H1 2014
  • Top 5 Clients of DAAN Gene, 2013
  • Top 5 Suppliers of DAAN Gene, 2013
  • Top 5 Suppliers of DAAN Gene, 2012
  • Revenue and Net Income of DAAN Gene, 2012-2017E
  • Revenue and Net Income of NYMPHAVN Biotechnology, 2009-2014
  • Revenue Breakdown of NYMPHAVN Biotechnology by Product, 2009-2014
  • Revenue Structure of NYMPHAVN Biotechnology by Product, 2009-2014
  • Gross Margin of NYMPHAVN Biotechnology, 2009-2014
  • Gross Margin of NYMPHAVN Biotechnology by Product, 2009-2014
  • Revenue and Gross Margin of Independent Clinical Laboratory of NYMPHAVN Biotechnology, 2009-H1 2014
  • Revenue and Net Income of NYMPHAVN Biotechnology, 2012-2017E
  • Revenue and Net Income of SurExam, 2011-2014
  • Gross Margin of SurExam, 2011-2014
  • Name List and Revenue of SurExam's Top 5 Clients, 2011-2013
  • Name List and Procurement of SurExam's Top 5 Suppliers, 2011-2013
  • Revenue and Net Income of SurExam, 2012-2017E
  • Some Strategic Partners of ADINOVO
  • Major Events of Kindstar Global
  • Revenue of Major Independent Clinical Laboratory Enterprises in China, 2009-2014
  • Net Income of Major Independent Clinical Laboratory Enterprises in China, 2009-2014
  • Net Profit Margin of Major Independent Clinical Laboratory Enterprises in China, 2009-2014
  • Gross Margin of Major Independent Clinical Laboratory Enterprises in China, 2009-2014
  • Revenue from Independent Clinical Laboratory of Major Independent Clinical Laboratory Enterprises in China, 2009-2014

Related Companies

  • Zhejiang D.A. Diagnostics Co., Ltd(300244.SZ)
  • Daan Gene Co.,Ltd.of Sun Yat-Sen University(002030.SZ)
Show More
Pricing